Χώρα: Ηνωμένο Βασίλειο
Γλώσσα: Αγγλικά
Πηγή: VMD (Veterinary Medicines Directorate)
Cephalonium
Ceva Animal Health Ltd
QJ51DB90
Cephalonium
Intramammary suspension
POM-V - Prescription Only Medicine – Veterinarian
Cattle
Antimicrobial intramammary
Expired
2017-12-13
Revised: October 2022 AN: 01598/2022 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Seclaris DC 250 mg Intramammary Suspension for dry cows 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each intramammary syringe of 3 g contains: ACTIVE SUBSTANCE: Cefalonium (as cefalonium dihydrate) 250 mg For the full list of excipients see section 6.1. 3. PHARMACEUTICAL FORM Intramammary suspension Shiny off-white to yellowish ointment. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (dry cow). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of subclinical mastitis at drying-off and the prevention of new bacterial infections of the udder during the non-lactating period of cows caused by _Staphylococcus aureus_, _Streptococcus agalactiae_, _Streptococcus dysgalactiae_, _Streptococcus uberis_, _Trueperella pyogenes_, _Escherichia coli_ and _Klebsiella_ spp susceptible to cefalonium. 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to cefalosporins, other ß-lactam antibiotics or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Use of the product should be based on susceptibility testing of bacteria isolated from milk samples obtained from the udder quarter(s) of each cow to be dried off. If this is not possible, therapy should be based on local (regional, farm level) risk based epidemiological information about the expected pathogen challenge, and Revised: October 2022 AN: 01598/2022 Page 2 of 5 susceptibility of target bacteria. Use of the product deviating from the instructions given in the SPC may contribute to the development of bacterial resistance to cefalonium which may also decrease the effectiveness of treatment with other beta lactams. Dry cow therapy protocols should take local and national policies on antimicrobial use into consideration, and undergo regular veterinary review. The feeding to calves of milk containing residues of c Διαβάστε το πλήρες έγγραφο